Klein, M. et al
"Prevention of pulmonary vascular and myocardial remodeling by the combined tyrosine and serine-/threonine kinase inhibitor, sorafenib, in pulmonary hypertension and right heart failure." European Respiratory Review
17.108
(2008):
72-73.
Web. 28 Mar. 2024.